Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 059588/0608 | |
| Pages: | 16 |
| | Recorded: | 04/13/2022 | | |
Attorney Dkt #: | 14875-0282US1 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17601831
|
Filing Dt:
|
10/06/2021
|
Publication #:
|
|
Pub Dt:
|
06/30/2022
| | | | |
Title:
|
THERAPEUTIC AGENT FOR UROLOGICAL CANCER WHICH IS CHARACTERIZED BY BEING ADMINISTERED WITH IL-6 INHIBITOR AND CCR2 INHIBITOR IN COMBINATION
|
|
Assignees
|
|
|
8-1, KAWADA-CHO, SHINJUKU-KU |
TOKYO, JAPAN 1628666 |
|
|
|
3-2 KAGAMIYAMA 1-CHOME, HIGASHI-HIROSHIMA-SHI |
HIROSHIMA, JAPAN 7398511 |
|
|
|
5-1, UKIMA 5-CHOME, KITA-KU |
TOKYO, JAPAN 1158543 |
|
Correspondence name and address
|
|
JANIS K. FRASER, PH.D., J.D.
|
|
FISH & RICHARDSON P.C.
|
|
P.O. BOX 1022
|
|
MINNEAPOLIS, MN 55440-1022
|
Search Results as of:
04/28/2024 03:54 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|